Background
Current findings on associations between whole grain (WG) intake and mortality are inconsistent and have not been summarized by meta-analysis.
Methods and Results
We searched for prospective cohort studies reporting associations between WG and mortality from all causes, CVD, and cancer through February 2016 in Medline, Embase, and clinicaltrials.gov, and further included unpublished results from National Health and Nutrition Examination Survey (NHANES) III and NHANES 1999–2004. Fourteen studies were eligible for analysis, which included 786,076 participants, 97,867 total deaths, 23,957 CVD deaths, and 37,492 cancer deaths. Pooled relative risks (RR, 95% confidence intervals [95%CIs]) comparing extreme WG categories (high vs. low) were 0.84 (0.80, 0.88; P<0.001, I2=74%, Pheterogeneity<0.001) for total mortality, 0.82 (0.79, 0.85; P<0.001, I2=0%, Pheterogeneity=0.53) for CVD mortality, and 0.88 (0.83, 0.94; P<0.001, I2=54%, Pheterogeneity=0.02) for cancer mortality. Intakes of WG ingredients in dry weight were estimated among studies reporting RRs for ≥3 quantitative WG categories, which were <50 grams/day among most study populations. The two-stage dose-response random-effects meta-analysis showed monotonic associations between WG intake and mortality (Pnonlinearity>0.05). For each 16 grams/day increase in WG (approximately 1 serving/day), RRs (95%CIs) of total, CVD, and cancer mortality were 0.93 (0.92, 0.94, P<0.001), 0.91 (0.90, 0.93, P<0.001), and 0.95 (0.94, 0.96, P<0.001), respectively.
Conclusions
Our meta-analysis demonstrated inverse associations of WG intake with total and cause-specific mortality, and findings were particularly strong and robust for CVD mortality. These findings further support current Dietary Guidelines for Americans, which recommends at least 3 servings/day of WG intake.